Company: ANIX
Filing Date: 2025-02-06
Form Type: DEF 14A
Source: 0001493152-25-005199
Chunk: 3

Company: Anixa Biosciences Inc
Filing Date: 2025-02-06
Form: DEF 14A
Chunk 3
---
0 Almaden Expressway, Suite 230

San Jose, CA 95118

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

To be held on March 20, 2025</div>

This proxy statement is furnished in connection with the solicitation of proxies by the Board of Directors (the “ Board”) of Anixa Biosciences, Inc. (the “ Company”) for use at the 2025 Annual Meeting of Stockholders of the Company and at all adjournments and postponements thereof (the “ Virtual Meeting”). The Virtual Meeting will be held at 10:00 a.m. Pacific time on Thursday, March, 20, 2025 on a virtual basis for the following purposes:

| 1. 
 2. 
 3. | To                                                                                                                               
 elect Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. as directors (the “Director Nominees”)   
 to serve on the Company’s Board for a one-year term that expires at the 2026 Annual Meeting of Stockholders, or until their      
 successors are elected and qualified;                                                                                            
 To                                                                                                                               
 approve on a non-binding, advisory basis the compensation of our named executive officers;                                       
 To                                                                                                                               
 ratify the appointment by the Board of Haskell & White LLP (the “Auditor”) as the Company’s independent                          
 registered public accounting firm for the fiscal year ending October 31, 2025;                                                   |
|:---|:---------------------------------------------------------------------------------------------------------------------------------|
| 4. | To                                                                                                                               
 select on a non-binding, advisory basis the frequency of conducting future stockholder advisory votes on named executive officer 
 compensation (which will be either every year, every two years or every three years); and                                        |
| 5. | To                                                                                                                               
 transact such other business as may properly come before the Virtual Meeting or any adjournment thereof.                         |

The Board unanimously recommends a vote “FOR” the approval of each of the Director Nominees, a vote “FOR” the approval on a non-binding, advisory basis of the compensation of our named executive officers, and a vote “FOR” the ratification of the appointment of the Auditor as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2025 and “FOR” one (1) year for the frequency of conducting future stockholder advisory votes on named executive officer compensation.

Stockholders of record